Item 8.01 Other Information | ||||||||
| Item 9.01 Financial Statements and Exhibits | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| Press Release | ||||||||
Table of Contents
| Item 8.01 | Other Information. |
Repros Therapeutics Inc. (the “Company”) today released the evaluation of the microscopic
assessment of tissues from a six-month mouse study conducted to satisfy a portion of the FDA
mandated two-species trials to demonstrate the lack of carcinogenic potential for new chemical
entities.
A copy of the Company’s press release is attached hereto as Exhibit 99.1. The press release
is incorporated by reference herein and the foregoing description is qualified in its entirety by
reference to such press release.
| Item 9.01 | Financial Statements and Exhibits. |
d. Exhibits
| Exhibit | ||||
| Number | Description | |||
| 99.1 | Press Release dated August 21, 2008 |
|||